American Journal of Kidney Diseases
Volume 52, Issue 3 , Pages 407-411 , September 2008

Kidney Disease in Childhood-Onset Diabetes

  • Robert G. Nelson, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Robert G. Nelson, MD, PhD, National Institutes of Health, 1550 East Indian School Rd, Phoenix, AZ 85014-4972

References 

  1. Knip M, Reunanen A, Virtanen SM, Nuutinen M, Viikari J, Akerblom HK. Does the secular increase in body mass in children contribute to the increasing incidence of type 1 diabetes?. Pediatr Diabetes. 2008 Jan 19;(Epub ahead of print)
  2. Hossain P, Kawar B, Nahas ME. Obesity and diabetes in the developing world—A growing challenge. N Engl J Med. 2007;356:213–215
  3. Bognetti E, Calori G, Meschi F, Macellaro P, Bonfanti R, Chiumello G. Prevalence and correlations of early microvascular complications in young type I diabetic patients: Role of puberty. J Pediatr Endocrinol Metab. 1997;10:587–592
  4. Holl RW, Grabert M, Thon A, Heinze E. Urinary excretion of albumin in adolescents with type 1 diabetes: Persistent versus intermittent microalbuminuria and relationship to duration of diabetes, sex, and metabolic control. Diabetes Care. 1999;22:1555–1560
  5. Holl RW, Pavlovic M, Heinze E, Thon A. Circadian blood pressure during the early course of type 1 diabetes (Analysis of 1,011 ambulatory blood pressure recordings in 354 adolescents and young adults). Diabetes Care. 1999;22:1151–1157
  6. Kostraba JN, Dorman JS, Orchard TJ, et al. Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care. 1989;12:686–693
  7. Olsen BS, Sjolie AK, Hougaard P, et al. The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes. J Diabetes Complications. 2004;18:160–164
  8. Pavlovic M, Holl RW, Haeberle U, et al. Angiotensin I converting enzyme and angiotensinogen gene polymorphisms related to 24-hour blood pressure in paediatric type I diabetes mellitus. Eur J Pediatr. 1999;158:18–23
  9. Mathiesen ER, Rønn B, Hensen T, Storm B, Deckert T. Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria. Diabetes. 1990;39:245–249
  10. Coonrod BA, Ellis D, Becker DJ, et al. Predictors of microalbuminuria in individuals with IDDM (Pittsburgh Epidemiology of Diabetes Complications Study). Diabetes Care. 1993;16:1376–1383
  11. The Microalbuminuria Collaborative Study Group. Predictors of the development of microalbuminuria in patients with type 1 diabetes mellitus: A seven-year prospective study. Diabetic Med. 1999;16:918–925
  12. Rossing P, Hougaard P, Parving H-H. Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients. Diabetes Care. 2002;25:859–864
  13. Hovind P, Tarnow L, Rossing P, et al. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: Inception cohort study. BMJ. 2004;328:1105–1109
  14. Schultz CJ, Konopelska-Bahu T, Dalton RN, et al. Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study (Oxford Regional Prospective Study Group). Diabetes Care. 1999;22:495–502
  15. Amin R, Widmer B, Prevost AT, et al. Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: Prospective observational study. BMJ. 2008;336:697–701
  16. Olsen BS, Sjolie A, Hougaard P, et al. A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes (Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood). J Diabetes Complications. 2000;14:295–300
  17. Jones CA, Leese GP, Kerr S, et al. Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus. Arch Dis Child. 1998;78:518–523
  18. Rudberg S, Ullman E, Dahlquist G. Relationship between early metabolic control and the development of microalbuminuria—A longitudinal study in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1993;36:1309–1314
  19. Krakoff J, Lindsay RS, Looker HC, Nelson RG, Hanson RL, Knowler WC. Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes. Diabetes Care. 2003;26:76–81
  20. Pavkov ME, Bennett PH, Knowler WC, Krakoff J, Sievers ML, Nelson RG. Effect of youth-onset type 2 diabetes on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA. 2006;296:421–426
  21. Savage PJ, Bennett PH, Senter RG, Miller M. High prevalence of diabetes in young Pima Indians: Evidence of phenotypic variation in a genetically isolated population. Diabetes. 1979;28:937–942
  22. Knowler WC, Pettitt DJ, Saad MF, Bennett PH. Diabetes mellitus in Pima Indians: Incidence, risk factors and pathogenesis. Diabetes Metab Rev. 1990;6:1–27
  23. Knowler WC, Bennett PH, Bottazzo GF, Doniach D. Islet cell antibodies and diabetes mellitus in Pima Indians. Diabetologia. 1979;17:161–164
  24. Dabelea D, Palmer JP, Bennett PH, Pettitt DJ, Knowler WC. Absence of glutamic acid decarboxylase antibodies in Pima Indian children with diabetes mellitus. Diabetologia. 1999;42:1265–1266
  25. Hanson RL, Ehm MG, Pettitt DJ, et al. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet. 1998;63:1130–1138
  26. Janssen RC, Bogardus C, Takeda J, Knowler WC, Thompson DB. Linkage analysis of acute insulin secretion with GLUT2 and glucokinase in Pima Indians and the identification of a missense mutation in GLUT2. Diabetes. 1994;43:558–563
  27. Muller YL, Infante AM, Hanson RL, et al. Variants in hepatocyte nuclear factor 4alpha are modestly associated with type 2 diabetes in Pima Indians. Diabetes. 2005;54:3035–3039
  28. WHO Multinational Study GroupLee ET, Keen H, Bennett PH, Fuller JH, Lu M. Follow-up of the WHO multinational study of vascular disease in diabetes: General description and morbidity. Diabetologia. 2001;44(suppl 2):S3–S13
  29. Lee ET, Lu M, Bennett PH, Keen H WHO Multinational Study Group. Vascular disease in younger-onset diabetes: Comparison of European, Asian and American Indian cohorts of the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001;44(suppl 2):S78–S81
  30. Hillier TA, Pedula KL. Complications in young adults with early-onset type 2 diabetes. Diabetes Care. 2003;26:2999–3005
  31. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354:2443–2451
  32. Podymow T, August P. Hypertension in pregnancy. Adv Chronic Kidney Dis. 2007;14:178–190

PII: S0272-6386(08)00992-X

doi: 10.1053/j.ajkd.2008.06.001

American Journal of Kidney Diseases
Volume 52, Issue 3 , Pages 407-411 , September 2008

Article Tools